Vaxxinity reports third quarter 2021 financial results and provides corporate updates

Dallas, dec. 23, 2021 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the third quarter ended september 30, 2021.

VAXX Ratings Summary

VAXX Quant Ranking